| Product Code: ETC9568943 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sweden mRNA Vaccine and Therapeutics Market Overview |
3.1 Sweden Country Macro Economic Indicators |
3.2 Sweden mRNA Vaccine and Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 Sweden mRNA Vaccine and Therapeutics Market - Industry Life Cycle |
3.4 Sweden mRNA Vaccine and Therapeutics Market - Porter's Five Forces |
3.5 Sweden mRNA Vaccine and Therapeutics Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.6 Sweden mRNA Vaccine and Therapeutics Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Sweden mRNA Vaccine and Therapeutics Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.8 Sweden mRNA Vaccine and Therapeutics Market Revenues & Volume Share, By End user, 2021 & 2031F |
4 Sweden mRNA Vaccine and Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases |
4.2.2 Growing government support for vaccination programs |
4.2.3 Rising investments in research and development for mRNA therapeutics |
4.3 Market Restraints |
4.3.1 High development costs associated with mRNA vaccine and therapeutics |
4.3.2 Regulatory challenges and approval process |
4.3.3 Limited manufacturing capacity for mRNA vaccines |
5 Sweden mRNA Vaccine and Therapeutics Market Trends |
6 Sweden mRNA Vaccine and Therapeutics Market, By Types |
6.1 Sweden mRNA Vaccine and Therapeutics Market, By Vaccine Type |
6.1.1 Overview and Analysis |
6.1.2 Sweden mRNA Vaccine and Therapeutics Market Revenues & Volume, By Vaccine Type, 2021- 2031F |
6.1.3 Sweden mRNA Vaccine and Therapeutics Market Revenues & Volume, By Self-amplifying mRNA-based Vaccines, 2021- 2031F |
6.1.4 Sweden mRNA Vaccine and Therapeutics Market Revenues & Volume, By Conventional Non-amplifying mRNA-based Vaccines, 2021- 2031F |
6.2 Sweden mRNA Vaccine and Therapeutics Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Sweden mRNA Vaccine and Therapeutics Market Revenues & Volume, By Cancer, 2021- 2031F |
6.2.3 Sweden mRNA Vaccine and Therapeutics Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.2.4 Sweden mRNA Vaccine and Therapeutics Market Revenues & Volume, By Autoimmune Diseases, 2021- 2031F |
6.2.5 Sweden mRNA Vaccine and Therapeutics Market Revenues & Volume, By Other, 2021- 2031F |
6.3 Sweden mRNA Vaccine and Therapeutics Market, By Treatment Type |
6.3.1 Overview and Analysis |
6.3.2 Sweden mRNA Vaccine and Therapeutics Market Revenues & Volume, By Monoclonal Antibody, 2021- 2031F |
6.3.3 Sweden mRNA Vaccine and Therapeutics Market Revenues & Volume, By Gene Therapy, 2021- 2031F |
6.3.4 Sweden mRNA Vaccine and Therapeutics Market Revenues & Volume, By Cell Therapy, 2021- 2031F |
6.3.5 Sweden mRNA Vaccine and Therapeutics Market Revenues & Volume, By Other, 2021- 2031F |
6.4 Sweden mRNA Vaccine and Therapeutics Market, By End user |
6.4.1 Overview and Analysis |
6.4.2 Sweden mRNA Vaccine and Therapeutics Market Revenues & Volume, By Research Laboratories and Organizations, 2021- 2031F |
6.4.3 Sweden mRNA Vaccine and Therapeutics Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.4 Sweden mRNA Vaccine and Therapeutics Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.5 Sweden mRNA Vaccine and Therapeutics Market Revenues & Volume, By Others, 2021- 2031F |
7 Sweden mRNA Vaccine and Therapeutics Market Import-Export Trade Statistics |
7.1 Sweden mRNA Vaccine and Therapeutics Market Export to Major Countries |
7.2 Sweden mRNA Vaccine and Therapeutics Market Imports from Major Countries |
8 Sweden mRNA Vaccine and Therapeutics Market Key Performance Indicators |
8.1 Research and development funding for mRNA vaccine and therapeutics |
8.2 Number of clinical trials for mRNA products |
8.3 Adoption rate of mRNA vaccines and therapeutics by healthcare providers |
8.4 Patient acceptance and willingness to receive mRNA-based treatments |
8.5 Rate of technological advancements in mRNA vaccine and therapeutics development |
9 Sweden mRNA Vaccine and Therapeutics Market - Opportunity Assessment |
9.1 Sweden mRNA Vaccine and Therapeutics Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
9.2 Sweden mRNA Vaccine and Therapeutics Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Sweden mRNA Vaccine and Therapeutics Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.4 Sweden mRNA Vaccine and Therapeutics Market Opportunity Assessment, By End user, 2021 & 2031F |
10 Sweden mRNA Vaccine and Therapeutics Market - Competitive Landscape |
10.1 Sweden mRNA Vaccine and Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 Sweden mRNA Vaccine and Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here